Mortality among patients with hip fractures in the non-DM, OAD, and insulin cohorts
| Mortality | Model I | Model II | ||||||
| No | Yes | |||||||
| n | (%) | n | (%) | Adjusted HR (95% CI) | P value | Adjusted HR (95% CI) | P value | |
| Non-DM cohort | 2263 | −82.4 | 482 | −17.6 | Ref | |||
| OAD cohort | 2020 | (85.1) | 353 | (14.9) | 0.86 (0.75 to 0.98) | 0·026 | Ref | |
| Insulin cohort | 276 | (74.2) | 96 | (25.8) | 1.48 (1.19 to 1.85) | <0·001 | 1.69 (1.35 to 2.13) | <0.001 |
Adjusted for age, sex, payroll bracket table, anesthesia type, and Charlson Comorbidity Index score.
Model I: comparison among the non-DM (ref), OAD, and insulin cohorts.
Model II: comparison between the OAD (ref) and insulin cohorts.
DM, diabetes mellitus; OAD, oral antidiabetic drug; ref, reference.